dosedrugsOnlineOfflineع
You're offline — running on data saved to your device.
cerebrolysin 215.2mg/ml i.m./i.v. 10 amps (1ml)
سيربرولايسين 215.2مجم/مل 10 أمبولات للحقن عضل/وريد
cerebrolysin · 215.2mg/ml
320EGP
Available
Active ingredient
cerebrolysin
Strength
215.2mg/ml
Form
ampoule
Manufacturer
ever neuro pharma > b.p pharma
Route
injection

Uses

Used as a nootropic and neuroprotective agent in the management of Alzheimer's disease, vascular dementia, traumatic brain injury, and stroke recovery. May support cognitive function and neurological rehabilitation.

Do not use if

Contraindicated in known hypersensitivity to cerebrolysin or any excipient. Contraindicated in severe renal impairment and status epilepticus.

Side effects

Generally well tolerated. Reported side effects include dizziness, agitation, increased sweating, loss of appetite, and injection-site reactions. Rare cases of hypersensitivity reactions have been reported.

Warnings

Use with caution in patients with epilepsy as it may lower the seizure threshold. Contains active peptide fractions; monitor patients with known allergies carefully.

How it works

Cerebrolysin is a standardised mixture of low-molecular-weight neuropeptides and free amino acids derived from purified porcine brain proteins. It exerts neurotrophic effects similar to endogenous nerve growth factors, promoting neuronal survival, plasticity, and repair.

Storage

Store between 15–25°C, protected from light. Do not freeze. Keep in original packaging.